Qkine, a leading manufacturer of high purity bioactive proteins, is pleased to announce its new sales distribution agreement with leading Turkish cell biology and stem cell reagent supplier Pitagen.
Qkine is pleased to announce a new UK & Ireland sales distribution agreement with SLS, the largest independent supplier of laboratory equipment, chemicals, and consumables in the UK.
Qkine are delighted that our eel FGF-2 proteins have elicited interest in Japan, recently the Nikkei Biotechnology & Business magazine have published an article focussing on the 145 and 154 amino acid versions of eel FGF-2, and the contribution Qkine species specific growth factors can have on the cultured seafood industry.
Qkine announces the provision of a new range of high quality food grade growth factors as part of our commitment to driving innovation in the functional recombinant growth factor supply chain for emerging sectors including cultivated meat, fish, fat and dairy.
NAPIC is a £38m centre dedicated to developing acceptable and planet-friendly alternatives to animal proteins led by researchers from the University of Leeds, James Hutton Institute, University of Sheffield and Imperial College London.
In this edition, we are excited to announce a price freeze moving into 2025, our win of Scale-up of the Year in the Cambridge Business Awards. We also share our latest hematopoietic stem cells blog, new products IL-2 and activin E PLUS and a new application note on growth factor stability.
As part of our commitment to supporting our customers and their science in economically difficult times, we have decided to hold our prices into 2025.
Our latest investment in our mission at Qkine to produce the highest quality growth factors for research. The most state-of-the-art automated system which fills, labels and caps vials with minimal manual intervention.
Qkine wins 'Scale-up of the Year' at the 2024 Cambridge Independent Business Awards On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of R&D and Collaborations joined some of the most impressive Cambridge business leaders for an exciting evening of networking and entertainment at the [...]
In this edition, we are excited to announce our complete transition to animal origin-free (AOF) manufacturing for all recombinant proteins. This ensures the highest quality and consistency for researchers relying on these critical components. Additionally, discover our latest application notes featuring AOF BDNF and GDNF for neural differentiation and thermostable FGF-2 and TGF-β1 for weekend-free iPSC culture.
© 2024 Qkine Ltd. Company number 10470662 registered in England and Wales. All rights reserved
